Perelman School of Medicine

Anil K. Rustgi, MD, chief of Gastroenterology in the Perelman School of Medicine at the University of Pennsylvania, is once again the recipient of a prestigious Research Professor Award from the American Cancer Society (ACS).

For the third of all epilepsy patients who don’t respond to medication, an alternative is to locate the small cluster of neurons that act as the seed of a seizure’s aberrant electrical activity and surgically remove it. Unfortunately, such surgeries often fail to bring any relief.

The amygdala, a small structure at the front end of the brain’s temporal lobe, has long been associated with negative behaviors generally, and specifically with fear. But new research from Michael Platt, the James S.

Whether aspirin may help prevent or reduce the risk of breast cancer remains a hotly debated research question. While past studies have indicated a potential benefit, most recently in hormone receptor-positive breast cancers, one new study from Penn Medicine suggests otherwise.

Combining the new breast cancer drug palbociclib with paclitaxel (Taxol) shrank tumors in nearly half of patient with estrogen-receptor (ER) positive breast cancer, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

Many BRCA 1/2-negative patients choose to proceed with comprehensive testing for genetic mutations that increase cancer risk, and when presented with counseling before and after testing, most make informed decisions and experience decreased levels of anxiety, according to new research from the Perelman School of Medicine at the University o

Medical students in Emergency Departments often perform an initial evaluation of stable patients prior to supervising residents or attending physicians, who meanwhile provide care to other patients.

In the first known study to examine the prevalence and treatment of psoriasis in older Americans, experts from the Perelman School of Medicine at the University of Pennsylvania have found that black patients receiving Medicare are less likely to receive biologic therapies –medications derived from human or animal cells or tissues – for the treatment of m

Men taking androgen deprivation therapy (ADT) for prostate cancer were almost twice as likely to be diagnosed with Alzheimer’s disease in the years that followed than those who didn’t undergo the therapy, an analysis of medical records from two large hospital systems by Penn Medicine and Stanford University researchers has shown.

In the first known study to examine the prevalence and treatment of psoriasis in older Americans, experts from the Perelman School of Medicine at the University of Pennsylvania have found that black patients receiving Medicare are less likely to receive biologic therapies –medications derived from human or animal cells or tis